The CORCINCH-HF study, which the Heart Hospital of New Mexico at Lovelace Medical Center is the first in the state to join, ...

Saint Francis is in the middle of a two-year double-blind clinical trail for a device that could potentially help people with congestive heart failure. When Gail Knox was diagnosed with a type of ...

There used to be no specific treatments for heart failure with preserved ejection fraction, but recent clinical trials show ...

The following is a summary of "Impact of sodium-glucose cotransporter‐2 inhibitors in patients with recent versus previous ...

The initial clinical assessments elicited stark awareness of a syndromic condition of varied causes (originally rheumatic heart disease, hypertension, and coronary disease) characterized by abysmal ...

Peripheral edema is a not too uncommon finding with direct vasodilators and in most cases of treatment with these drugs does not reflect developed CHF. The authors of the original publication ...

BioCardia (BCDA) announced completion of source data verification and freezing of primary outcomes data in the double-blind randomized ...

Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies.

Researchers at MIT and Harvard Medical School have a new, noninvasive deep learning approach to predict the risk of heart ...

Every year, 900,000 Americans are caught by surprise by the symptoms of a pulmonary embolism: a sudden shortness of breath, ...

Congestive heart failure (CHF) is a condition where the heart becomes too weak to pump blood efficiently. Over time, this ...